Target intelligence / Profile preview

RNA, U6 small nuclear 729, pseudogene (RNU6-729P)

Target
RNU6-729P
Molecular classification
Other (pseudogene, non-coding RNA)
01

Overview

RNA, U6 small nuclear 729, pseudogene (RNU6-729P) is a pseudogene belonging to the U6 small nuclear RNA family. As a pseudogene, RNU6-729P does not produce a functional RNA or protein product. U6 small nuclear RNAs (snRNAs) are essential components of the spliceosome complex, playing a central role in pre-mRNA splicing, but RNU6-729P itself lacks function due to loss of coding or regulatory capacity[1][4][5]. Pseudogenes like RNU6-729P are DNA sequences resembling functional genes but made nonfunctional by mutations; while some pseudogenes serve regulatory roles in gene expression or disease (for instance, through RNA interference mechanisms), there is no evidence RNU6-729P has such properties[2]. It is not considered a therapeutic target, nor is it directly associated with any known diseases or drugs. Notes: - RNU6-729P is not a functional gene, receptor, or enzyme; it is a pseudogene, so is_incorrect: true for being a therapeutic target. - Entries such as interacting_drugs or mechanism_of_action are null, as pseudogenes generally are not targeted by drugs. - U6 snRNA itself is functionally important but this entry is a nonfunctional genomic copy that does not produce U6 snRNA.

Other names
RNU6-729PU6 small nuclear RNA 729 pseudogene
02

Biological functions

Other (does not encode a functional product; potential regulatory noncoding RNA functions are theoretical and not validated for this specific pseudogene)
03

Disease associations

Other (no direct disease role known for RNU6-729P; some pseudogenes may be involved in gene regulation or disease, but no evidence for this one)

Beyond the preview

Go deeper on RNA, U6 small nuclear 729, pseudogene (RNU6-729P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 729, pseudogene (RNU6-729P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call